Gorrissen Federspiel

Life Sciences & Healthcare

Martin Dræbye Gantzhorn co-heads the firm's Life Sciences & Healthcare sector team, which provides leading advice to innovative international and national life sciences companies, including advisory and litigation support within regulatory, market access, transactions, capital markets/PE and product liability.

Martin has decades of experience assisting life sciences companies at every step of the product life cycle and is an internationally recognised expert within regulatory life science, product liability and IP/trade secrets litigation.

Knowing the pharmaceutical and medical device companies from within, he assists on various matters relating to (Nordic) market access, regulatory data protection, market strategies, regulatory approvals, PPP/OPS, pricing, clinical trials/studies, promotional compliance, PV, SOPs/audits and product liability.

Gorrissen Federspiel 2024 - Partner, Gorrissen Federspiel since 2024 Bech-Bruun 2017 - 2024 Horten 2010 --2016

Board Member, Life Science Law DK IBA Life Science & Healthcare Committee Officer, European Liaison EPLAW (European Patent Lawyers Association) EFLA (European Food Lawyers Association) EPLA (European Pharmaceutical Lawyers Association) LES (Licensing Executives Society), Past President LES Scandinavia IBA (International Bar Association) INTA (International Trademark Association

Master of Laws, University of Copenhagen 2003 Admitted to the Danish Bar 2006 Admitted to the Bar of the High Courts 2014